Table 1.
Patient, disease, and treatment characteristics between patients who underwent UE and PE.
| Variable | All patients | Planned excision | Unplanned excision |
|---|---|---|---|
| Number | 245 | 211 | 34 |
|
| |||
| Median age | 57 | 57 | 64 |
|
| |||
| Median tumor Size | 7.9 cm | 8.5 cm | 4 cm |
|
| |||
| Stage | I: 46 (18.7%) II: 62 (25.3%) III: 137 (56%) |
I: 40 (19%) II: 46 (22%) III: 125 (59%) |
I: 6 (17.7%) II: 16 (47%) III: 12 (35.3%) |
|
| |||
| Grade | Low: 47 (19.1%) Intermediate: 20 (8.2%) High: 178 (72.7%) |
Low: 45 (18.4%) Intermediate: 15 (6.1%) High: 185 (75.5%) |
Low: (3%) Intermediate: 5 (14.7%) High: 28 (82.3%) |
|
| |||
| Histology | Undifferentiated: 56 (22.9%) Leiomyosarcoma/liposarcoma: 77 (31.4%) Synovial: 45 (18.4%) Other: 67 (27.3%) |
Undifferentiated: 51 (24.1%) Leiomyosarcoma/liposarcoma: 68 (32.2%) Synovial: 38 (18%) Other: 48 (22.7%) |
Undifferentiated: 6 (17.6%) Leiomyosarcoma/liposarcoma: 9 (26.5%) Synovial: 7 (20.6%) Other: 12 (35.3%) |
|
| |||
| Tumor location | Upper extremity: 64 (26.1%) Lower extremity: 181 (73.9%) |
Upper extremity: 50 (23.7%) Lower extremity: 161 (76.3%) |
Upper extremity: 13 (38.2%) Lower extremity: 21 (61.8%) |
|
| |||
| Subcutaneous disease (TXa) | 45 (18.4%) | 36 (17%) | 9 (26.5%) |
|
| |||
| Timing of RT | No RT: 36 (14.7%) Preoperative: 174 (71%) Postoperative: 35 (14.3%) |
No RT: 24 (11.4%) Preoperative: 163 (77.2%) Postoperative: 24 (11.4%) |
No RT: 12 (35.4%) Preoperative: 11 (32.3%) Postoperative (alone or after reexcision): 11 (32.3%) |
|
| |||
| Chemotherapy | 68 (28%) | 67 (32%) | 1 (3%) |